PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31783709-0 2019 Sinulariolide Inhibits Gastric Cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways. sinulariolide 0-13 AKT serine/threonine kinase 1 Homo sapiens 136-139 31783709-6 2019 Immunostaining analysis showed that sinulariolide significantly reduced the protein expressions of MMP-2, MMP-9, and uPA, but the expressions of TIMP-1 and TIMP-2 were increased, while FAK, phosphorylated PI3K, phosphorylated AKT, phosphorylated mTOR, phosphorylated JNK, phosphorylated p38MAPK, and phosphorylated ERK decreased in expression with increasing sinulariolide concentration. sinulariolide 36-49 AKT serine/threonine kinase 1 Homo sapiens 226-229 31783709-7 2019 From the results, we inferred that sinulariolide treatment in AGS and NCI-N87 cells reduced the activities of MMP-2 and MMP-9 via the FAK/PI3K/AKT/mTOR and MAPKs signaling pathways, further inhibiting the invasion and migration of these cells. sinulariolide 35-48 AKT serine/threonine kinase 1 Homo sapiens 143-146 28767067-0 2017 Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells. sinulariolide 0-13 AKT serine/threonine kinase 1 Homo sapiens 128-131 26204832-0 2015 Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways. sinulariolide 0-13 AKT serine/threonine kinase 1 Homo sapiens 151-154 26204832-6 2015 Sinulariolide also exerted an inhibitory effect on phosphorylation of c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinases (ERK), phosphatidylinositol 3-kinase (PI3K), Akt, Focal adhesion kinase (FAK), growth factor receptor-bound protein 2 (GRB2). sinulariolide 0-13 AKT serine/threonine kinase 1 Homo sapiens 185-188 26204832-7 2015 Taken together, these results demonstrated that sinulariolide could inhibit hepatocellular carcinoma cell migration and invasion and alter HA22T cell metastasis by reduction of MMP-2, MMP-9, and uPA expression through the suppression of MAPKs, PI3K/Akt, and the FAK/GRB2 signaling pathway. sinulariolide 48-61 AKT serine/threonine kinase 1 Homo sapiens 249-252